Creative Planning increased its holdings in Haleon plc (NYSE:HLN – Free Report) by 15.2% during the third quarter, HoldingsChannel.com reports. The fund owned 285,227 shares of the company’s stock after buying an additional 37,566 shares during the period. Creative Planning’s holdings in Haleon were worth $3,018,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also modified their holdings of HLN. AE Wealth Management LLC increased its stake in Haleon by 6.1% in the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company’s stock valued at $159,000 after buying an additional 1,098 shares during the period. Cardinal Capital Management increased its stake in Haleon by 2.5% in the 2nd quarter. Cardinal Capital Management now owns 46,231 shares of the company’s stock valued at $382,000 after buying an additional 1,140 shares during the period. Endowment Wealth Management Inc. increased its stake in Haleon by 9.9% in the 2nd quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company’s stock valued at $106,000 after buying an additional 1,161 shares during the period. Portside Wealth Group LLC increased its stake in Haleon by 2.7% in the 2nd quarter. Portside Wealth Group LLC now owns 44,985 shares of the company’s stock valued at $372,000 after buying an additional 1,182 shares during the period. Finally, Hexagon Capital Partners LLC increased its stake in Haleon by 18.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock valued at $84,000 after buying an additional 1,238 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.
Haleon Stock Performance
NYSE:HLN opened at $9.85 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a fifty-two week low of $7.70 and a fifty-two week high of $10.80. The stock has a market cap of $44.98 billion, a PE ratio of 32.83, a price-to-earnings-growth ratio of 2.90 and a beta of 0.26. The firm’s fifty day simple moving average is $10.23 and its 200-day simple moving average is $9.20.
Haleon Cuts Dividend
The firm also recently disclosed a semi-annual dividend, which was paid on Thursday, September 19th. Investors of record on Friday, August 16th were given a $0.0514 dividend. The ex-dividend date was Friday, August 16th. This represents a dividend yield of 1.6%. Haleon’s dividend payout ratio is presently 33.33%.
Wall Street Analyst Weigh In
Several brokerages have issued reports on HLN. The Goldman Sachs Group cut shares of Haleon from a “buy” rating to a “neutral” rating in a research note on Tuesday, August 6th. UBS Group raised shares of Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. Berenberg Bank initiated coverage on shares of Haleon in a research note on Tuesday, August 6th. They set a “buy” rating on the stock. Finally, Morgan Stanley upped their price target on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research note on Friday, September 20th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Haleon currently has an average rating of “Buy” and a consensus price target of $10.95.
Check Out Our Latest Report on HLN
Haleon Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Read More
- Five stocks we like better than Haleon
- What is an Earnings Surprise?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Insider Buying Explained: What Investors Need to Know
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 10/21- 10/25
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.